SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9480	Companies
185535	Keywords
117927	Articles
99378	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 05/27/2024 at 07:00, 1 year 6 months ago

Communiqué de presse : La FDA accorde un examen prioritaire au Sarclisa pour le traitement des patients atteints d’un myélome multiple nouvellement diagnostiqué non éligibles à une transplantation
La FDA accorde l'examen prioritaire au Sarclisa pour le traitement du myélome multiple nouvellement diagnostiqué non éligibles à une transplantation. Sanofi annonce des résultats positifs de l'étude IMROZ

FDA Sanofi Myélome Multiple Sarclisa Examen Prioritaire
BRIEF

published on 05/21/2024 at 07:35, 1 year 6 months ago

Sanofi, Formation Bio, and OpenAI Announce AI Collaboration

Collaboration AI Drug Development Sanofi OpenAI Formation Bio
BRIEF

published on 05/21/2024 at 07:35, 1 year 6 months ago

Sanofi, Formation Bio et OpenAI annoncent une collaboration en matière d'IA

Collaboration Développement De Médicaments IA Sanofi OpenAI Biographie De La Formation
PRESS RELEASE

published on 05/21/2024 at 07:30, 1 year 6 months ago

Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
Sanofi, Formation Bio, and OpenAI collaborate to accelerate drug development with AI-powered software. The partnership aims to bring new medicines more efficiently

Collaboration Drug Development Sanofi OpenAI Formation Bio
PRESS RELEASE

published on 05/21/2024 at 07:30, 1 year 6 months ago

Communiqué de presse : Sanofi, Formation Bio et OpenAI annoncent une coopération de première classe autour de l’IA
Sanofi, Formation Bio et OpenAI annoncent une coopération pour développer des logiciels alimentés par l'IA afin d'accélérer le développement de médicaments. Première collaboration de ce genre dans les industries pharmaceutiques et des sciences de la vie

IA Sanofi Développement De Médicaments OpenAI Formation Bio
BRIEF

published on 05/20/2024 at 22:59, 1 year 6 months ago

Sanofi: April 2024 Voting Rights and Shares Information

Voting Rights Shares Financial Disclosure April 2024 Sanofi
BRIEF

published on 05/20/2024 at 22:59, 1 year 6 months ago

Sanofi : Informations sur les droits de vote et les actions d'avril 2024

Actions Droit De Vote Divulgation Financière Avril 2024 Sanofi
PRESS RELEASE

published on 05/20/2024 at 22:54, 1 year 6 months ago

Sanofi: Information concerning the total number of voting rights and shares - April 2024
Sanofi provides total number of issued shares and voting rights as per French Commercial Code and AMF regulations for April 30, 2024

Share Capital Voting Rights French Commercial Code AMF Regulations Sanofi
PRESS RELEASE

published on 05/20/2024 at 22:54, 1 year 6 months ago

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Avril 2024
Annonce du nombre total de droits de vote et d'actions de Sanofi selon les réglementations en vigueur. Informations disponibles sur le site internet de l'entreprise

Autorité Des Marchés Financiers Droits De Vote Actions Relations Investisseurs Sanofi
BRIEF

published on 05/20/2024 at 20:20, 1 year 6 months ago

Dupixent® réduit les exacerbations de la BPCO selon une étude de phase III

FDA Étude Clinique Inflammation BPCO Dupixent

Accesswire

Published on 12/05/2025 at 19:50, 25 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 55 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 30 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 55 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 2 hours 15 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 17 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 48 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 59 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 23 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 29 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 57 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 57 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 4 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 4 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 16 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE